No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLymphoma & Plasma Cell DisordersLung CancerLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersGenitourinary CancerBreast Cancer
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationMelanomaLymphoma & Plasma Cell DisordersLung Cancer
Further Support for CRC Screening to Start at Age 45: Meta-AnalysisApril 12, 2024OncologyColon and Rectal
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncologyProstate Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMelanomaMixed Topics
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 ExpressionApril 9, 2024
EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate DiscontinuationApril 8, 2024OncologyProstate Cancer
New Trials in Prostate Cancer: Could Your Patient Benefit?April 8, 2024Genitourinary CancerProstate Cancer
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024OncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Prostate Cancer Tsunami Coming, Experts CautionApril 5, 2024Genitourinary CancerOncologyProstate Cancer
